The results presented in this manuscript highlight for the first time the reversal of EMT in pancreatic cancer cells following FTO inhibition and, therefore, their responsibility for inhibiting pancreatic cancer progression. This evidence concerns the gene FTO and familial pancreatic carcinoma.